Correlation Between Rubius Therapeutics and G1 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Rubius Therapeutics and G1 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rubius Therapeutics and G1 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rubius Therapeutics and G1 Therapeutics, you can compare the effects of market volatilities on Rubius Therapeutics and G1 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rubius Therapeutics with a short position of G1 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rubius Therapeutics and G1 Therapeutics.
Diversification Opportunities for Rubius Therapeutics and G1 Therapeutics
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Rubius and GTHX is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Rubius Therapeutics and G1 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on G1 Therapeutics and Rubius Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rubius Therapeutics are associated (or correlated) with G1 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of G1 Therapeutics has no effect on the direction of Rubius Therapeutics i.e., Rubius Therapeutics and G1 Therapeutics go up and down completely randomly.
Pair Corralation between Rubius Therapeutics and G1 Therapeutics
If you would invest 715.00 in G1 Therapeutics on September 1, 2024 and sell it today you would earn a total of 0.00 from holding G1 Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rubius Therapeutics vs. G1 Therapeutics
Performance |
| Timeline |
| Rubius Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| G1 Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Strong
Rubius Therapeutics and G1 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rubius Therapeutics and G1 Therapeutics
The main advantage of trading using opposite Rubius Therapeutics and G1 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rubius Therapeutics position performs unexpectedly, G1 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in G1 Therapeutics will offset losses from the drop in G1 Therapeutics' long position.The idea behind Rubius Therapeutics and G1 Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| G1 Therapeutics vs. Allogene Therapeutics | G1 Therapeutics vs. Heron Therapeuti | G1 Therapeutics vs. Annexon | G1 Therapeutics vs. Sangamo Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |